GALDERMA GROUP AG GALDY · Stock Open GALDERMA GROUP AG in new tab
GALDERMA GROUP AG Analysis (GALDY)
Is GALDERMA GROUP AG a good investment? GALDERMA GROUP AG (GALDY) is currently trading at 38.91 USD.
In terms of valuation, the stock trades at a P/E ratio of 54.23. This high multiple suggests investors have priced in significant future growth expectations.
For income investors, GALDERMA GROUP AG pays a dividend yield of 0.23%. With a payout ratio of 12%, the dividend appears sustainable.
Investor FAQ
Does GALDERMA GROUP AG pay a dividend?
Yes, it pays an annual dividend of 0.09 USD (0.23% yield).
What asset class is GALDERMA GROUP AG?
GALDERMA GROUP AG is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
Company Profile
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
| Year | Total Dividends |
|---|---|
| ▸2027 |
0.09 USD
|
| April 28, 2027 (estimated) | 0.0885 |
| ▸2026 |
0.09 USD
|
| April 27, 2026 | 0.0885 |
| ▸2025 |
0.04 USD
|
| April 28, 2025 | 0.0362 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| GALDERMA GROUP AG | Apr 27, 2026 | Paid | 0.08852 USD |
Community Discussion